MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clinimag.2022.11.014

Медицинская библиотека · Clinical imaging · 2022

Prognostic role of baseline 18F-FDG pet/CT in stage I and stage ii non-small cell lung cancer.

Dondi Francesco, Albano Domenico, Bellini Pietro, Cerudelli Elisabetta, Treglia Giorgio, Bertagna Francesco

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

investigate the prognostic role of baseline 18F-FDG PET/CT in stage I-II NSCLC.

MATERIAL AND

METHODS

296 patients were included. Clinicopathological features and PET/CT semiquantitative parameters [standardized uptake value (SUV) body weight max (SUVmax), SUV body weight mean (SUVmean), SUV lean body mass (SUVlbm), SUV body surface area (SUVbsa), metabolic tumor volume (MTV), total lesion glycolysis (TLG), ratio SUVmax/liver (S-L) and ratio SUVmax/blood-pool (S-BP) were extracted]. Anova and Kruskall-Wallis tests were used to assess the relationship between these parameters. Kaplan-Meier, univariate and multivariate analysis were performed to search independent prognostic factors for progression free (PFS), overall survival (OS) and disease specific survival (DSS).

RESULTS

Correlation between PET/CT semiquantitative parameters and histology, stage, size, grading and presence of nodal metastasis were reported. Mean PFS was 28.1 months, relapse/progression of disease occurred in 85 patients (28.7%). Mean OS was 33.3 months, death occurred in 43 patients (14.5%); specific death by NSCLC occurred in 26 subjects (8.8%). Kaplan-Meier analyses revealed most of semiquantitative parameters as predictive for PFS, OS and DSS. For DSS, this was confirmed when dividing between patients with surgery and surgery with other therapies. SUVmax, SUVmean, SUVlbm, SUVbsa and S-L revealed to be independent prognosticators for OS and DSS. S-BP was an independent prognosticator for DSS. SUVmax, SUVmean, SUVlbm, S-L and S-BP were confirmed as independent prognosticators for DSS in the group of patients treated with surgery and subsequent adjuvant therapy.

CONCLUSION

Baseline 18F-FDG PET/CT semiquantitative parameters are confirmed as prognostic tools for stage I-II NSCLC, in particular for DSS.

Для цитирования: Dondi Francesco, Albano Domenico, Bellini Pietro, Cerudelli Elisabetta, Treglia Giorgio, Bertagna Francesco. Prognostic role of baseline 18F-FDG pet/CT in stage I and stage ii non-small cell lung cancer.. Clinical imaging. 2022. DOI: 10.1016/j.clinimag.2022.11.014.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.